Objective: This study aims to investigate the relationship between BRAF V600E gene
mutation and the clinical and pathologic characteristics of patients with papillary thyroid …

Papillary thyroid cancers often occur as microcarcinoma. Some papillary thyroid
microcarcinoma (PTMC) have been considered to be high aggressive according to …

Purpose In this study, the relationship between the BRAFV600E mutation and the
clinicopathological features of papillary thyroid microcarcinoma (PTMC) was examined in a …

Objective: To evaluate the relationship between BRAF mutation and factors influencing the
prognosis of papillary thyroid microcarcinoma (PTMC). Methods: Clinical data from patients …

Abstract Background The BRAF V600E mutation, which accounts for about 60–80%
papillary thyroid carcinoma (PTC), has been identifiedas a prognostic marker for risk …

OBJECTIVE: To analyze the association of BRAF V600E mutation with ultrasonographic
(US) features and clinicopathologic characteristics in Chinese patients with papillary thyroid …

Object: Previous studies suggest BRAF V600E mutation is a marker for poor prognosis in
papillary thyroid cancer, however, its ability to further risk stratify papillary thyroid …

The prognostic value of the BRAFV600E mutation, resulting in poor clinical outcomes of
papillary thyroid carcinoma, has been generally confirmed. However, the association of …

Background Studies on the relationship between BRAF V600E mutation and the
clinicopathologic features of papillary thyroid carcinoma (PTC), risk of lymph node …

Abstract BRAF V600E mutation has emerged as a marker of aggressive behavior in
papillary thyroid carcinoma but its significance in microcarcinoma is not entirely clear. One …